Royal Bank of Canada
CPIX icon

Royal Bank of Canada’s Cumberland Pharmaceuticals CPIX Stock Holding History

Royal Bank of Canada’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+127
New +$489 ﹤0.01% 7202
2024
Q3 		– Sell
-47
Closed – – 6935
2024
Q2 		$0 Hold
47
– – ﹤0.01% 7116
2024
Q1 		$0 Sell
47
-91
-66% -$182 ﹤0.01% 7081
2023
Q4 		$0 Sell
138
-10
-7% -$18 ﹤0.01% 7179
2023
Q3 		$0 Sell
148
-163
-52% -$273 ﹤0.01% 7147
2023
Q2 		$0 Buy
+311
New +$537 ﹤0.01% 7310
2020
Q4 		– Sell
-2,152
Closed -$6K – 7082
2020
Q3 		$6K Buy
2,152
+9
+0.4% +$30 ﹤0.01% 6081
2020
Q2 		$7K Buy
2,143
+2,033
+1,848% +$7.39K ﹤0.01% 5940
2020
Q1 		$0 Buy
+110
New +$492 ﹤0.01% 6712
2019
Q4 		– Sell
-178
Closed -$1K – 6853
2019
Q3 		$1K Buy
+178
New +$990 ﹤0.01% 6418
2018
Q4 		– Sell
-2
Closed – – 6795
2018
Q3 		$0 Buy
+2
New +$12 ﹤0.01% 6743
2017
Q4 		– Sell
-3
Closed – – 6576
2017
Q3 		$0 Buy
+3
New +$21 ﹤0.01% 6736
2013
Q3 		– Sell
-7,013
Closed -$36K – 6103
2013
Q2 		$36K Buy
+7,013
New +$34.9K ﹤0.01% 4815

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Royal Bank of Canada's CPIX Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 127 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7202 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in CPIX as recently as Q2 2024.

Royal Bank of Canada first reported a position in CPIX in Q2 2013 and has held it in 13 quarters since. The position peaked at $36K in Q2 2013. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Royal Bank of Canada held 127 shares of Cumberland Pharmaceuticals worth $0 as of Q1 2026.
  • Cumberland Pharmaceuticals was a new Royal Bank of Canada position in Q1 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7202 holding.
  • Royal Bank of Canada first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
  • Royal Bank of Canada's Cumberland Pharmaceuticals position peaked at $36K in Q2 2013.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.